Treatment of tuberculosis;Therapie der Tuberkulose

Pneumologe

Volumn 16, Issue 2, 2019, Pages 117-130

  Diel, Roland ^a,b  

^a LungenClinic Grosshansdorf   (Germany)

^b Pneumologisches Forschungsinstitut An der LungenClinic Grosshansdorf Airway Research Center North ARCN Deutschen Zentrum für Lungenforschung   (Germany)

Author keywords

HIV coinfection; Multiple drug resistance; Mycobacterium tuberculosis infection; Outcome; Pulmonary tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; COMBINATION DRUG THERAPY; EXTRAPULMONARY TUBERCULOSIS; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LUNG TUBERCULOSIS; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PROGNOSIS;

EID: 85061362901     PISSN: 16135636     EISSN: 16136055     Source Type: Journal    
DOI: 10.1007/s10405-019-0234-x     Document Type: Article

References (12)

1. Weltgesundheitorganisation (WHO) (2017) Global tuberculosis control: WHO report 2017. WHO, Genf/Schweiz
2. Weltgesundheitsorganisation (WHO) (2016) WHO treatment guidelines for drug-resistant tuberculosis, 2016 update. October 2016 revision. WHO, Genf/Schweiz
3. Robert Koch-Institut (RKI) (2018) Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2017. RKI, Berlin
4. Schaberg T, Bauer T, Brinkmann F et al (2017) S2k-Leitline: Tuberkulose im Erwachsenenalter. Pneumologie 71:325–397
5. Loddenkemper R, Brönnecke M, Castell S, Diel R (2016) Tuberculosis and tobacco smoking. Pneumologie 70(1):17–22
6. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D (2003) Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 167:1472–1477
7. Weltgesundheitsorganisation (WHO) (2008) Guidelines for the programmatic management of drug-resistant tuberculosis. WHO, Genf/Schweiz
8. Weltgesundheitsorganisation (WHO) (2018) Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis. WHO/CDS/TB/2018.18. Geneva: World Health Organization. http://www.who.int/tb/publications/2018/rapid_communications_MDR/en/
9. Milburn H, Ashman N, Davies P et al (2010) Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax 65:557–570
10. Diel R, Loytved G, Nienhaus A et al (2011) Neue Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose. Gesundheitswesen 73:369–388
11. Detjen AK, Magdorf K (2009) Besonderheiten der Kindertuberkulose. Pneumologie 63:207–218
12. Feiterna-Sperling C, Brinkmann F, Adamczick C et al (2017) Consensus-based guidelines for diagnosis, prevention and treatment of tuberculosis in children and adolescents—A guideline on behalf of the German society for pediatric infectious diseases (DGPI). Pneumologie 71:629–680